Objective: Analytical dose calculation algorithms for Eclipse and Raystation treatment planning systems (TPS), as well as a Raystation Monte Carlo model are compared to corresponding measured point doses.
| INTRODUCTION
Many proton centers around the world are implementing pencil beam spot scanning as a preferred delivery method for proton therapy. Spot scanning beams have the ability to modulate energy as well as intensity without the use of apertures/collimators and compensators in the beamline.
1 At our center spot scanning techniques are exclusively used. When considering how to most effectively treat patients with proton therapy, different treatment planning system provide different advantages and disadvantages. 2,3 These differences in different treatment planning systems were discussed in various articles for photons [4] [5] [6] [7] [8] and for protons. [9] [10] [11] Pencil beam scanning can also be simulated with Monte Carlo models, 12 although this is more time consuming and not practical for everyday treatment planning.
At our center we use two commercially available clinical treatment planning systems (TPS), Eclipse and Raystation. In this work, we compare the analytical dose calculation algorithms for these systems, as well as for a Raystation Monte Carlo model to corresponding measured point doses. The main issues using analytical algorithms for range shifters are that the average proton energy decreases when scattering angle increases during the non-elastic scattering processes as shown in Lin et al., 12 especially for small fields or fields including a range shifter. 10, 11 We therefore compare the planning systems to quantify these inaccuracies.
| MATERIALS AND METHODS
The treatment planning system (TPS) and proton pencil beam calculation models used are Varian Eclipse v11 13 (Varian Medical Systems, Palo Alto, CA, USA), Raystation v5 pencil beam (PB), and Raystation v6 Monte Carlo (MC) (RaySearch Medical Laboratories AB, Stockholm, Sweden). [14] [15] [16] [17] [18] The TPS were modeled with the same beam data acquired during commissioning. 19, 20 To commission the TPS the integrated depth dose curves (IDDs) and spot profiles in air were measured over the entire range of energies available, starting from 245 MeV, 240 MeV, and then every 10 MeV down to 70 MeV. For both TPS only the spot profiles at one gantry angle could be used for commissioning, even though there is a change in full width half maximum of the spots as function of gantry angle. 20 We choose to use the spot profiles measured at gantry 0 every 10 MeV from 70 MeV to 245 MeV, and verified that the variation at other angles and among all treatment rooms are within 15%. In addition to the spot profiles in air at isocenter, they were also measured for both TPS at 10 cm and 20 cm above and below isocenter as well as for each range shifter commissioned. Range shifters provide dose coverage for more superficial tumors. For both TPS the 5.7 cm, 3.42 cm and 2.28 cm water equivalent thickness (WET) range shifters were commissioned. The range shifters were commissioned with an airgap of 26 cm. This distance is an approximation of what will be used clinically for most cases. Smaller airgaps will be used during planning, but might not always be possible because of patient couch collisions as the snout is extended.
Absolute calibration was done using the TRS398 protocol. 21 For
Eclipse the absolute dose measurement was done at a water equivalent depth of 2 cm for all the energies measured for the IDDs. 3 | RESULTS | 159 range shifter is small, two of the four plans had percentage differences in more than 3% and the measured doses are mostly higher than the TPS doses. For Raystation PB plans the measured doses are lower than the TPS doses for all the plans and 3 of the 4 plans have percentage differences higher than 3%, with a maximum of 7.16%. Comparing the TPS doses, the Raystation PB plans with a 5 cm range shifter give doses higher than those calculated by Eclipse by more than 3% for 3 of the 4 plans. This can in part be due to the slightly lower mass density of 1.00 g/cm 3 assigned for the water phantom in Raystation, compared to 1.024 g/cm 3 in Eclipse (for HU of 0), resulting in a difference in stopping power in water compared to Eclipse.
In Fig. 3 and In Neither of the analytical calculation models of the TPSs were accurate in calculating dose for plans with a 5 cm range shifter, with
Eclipse calculating doses mostly lower than measured doses and Raystation calculating doses higher than measured doses. This indi-
cates that neither TPS model the additional scattering in the range Both TPS had calculated doses more than 3% higher for a small shallow target of 2 9 2 9 2 cm 3 dimension. The same is not true for targets that are small but deeper, since plans with ranges larger than 10 cm and a SOBP of 1 cm were within 2%. Raystation PB point doses for plans with a range of 35 cm or larger were also not as accurate as for the other TPS used.
The distribution for the patient plans were similar for Eclipse and Raystation MC with a P-value of 0.59 for a two tailed unpaired t- 
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